Tuominen, Leena http://orcid.org/0000-0001-7764-7572
Ritmala-Castrén, Marita
Nikander, Pia
Mäkelä, Siru
Vahlberg, Tero
Leino-Kilpi, Helena
Funding for this research was provided by:
Helsingin ja Uudenmaan Sairaanhoitopiiri (M7100NRCVA)
Article History
Received: 4 June 2020
Accepted: 27 May 2021
First Online: 10 June 2021
Declarations
:
: Research ethics approval is obtained according to organisational policy from the Helsinki University Hospital (HUH) Ethics Committee (HUS/2115/2019) prior to conducting the research. Materials related to informed consent are available from the authors, if needed. Permission to conduct the study has been obtained from the Comprehensive Cancer Centre of HUH (HUS/83/29019). In the case of protocol amendments, e.g., changes to eligibility criteria, protocol, outcomes or analyses, they are communicated between members of the research group, ethics committee or organisation research board. The researcher will obtain written informed consent from eligible trial participants in connection with the first visit to the outpatient clinic before initiating chemotherapy treatment. Confidentiality is protected by maintaining the data in the organisation’s computer file that is secured with a password in order to protect confidentiality before and during the trial. In addition, the clinical data is collected by the researcher and not shared with anyone.
: Not applicable.
: The authors declare that they have no competing interests.